Core Points - The company announced that it will not lower the conversion price of its convertible bonds during the specified period [2] - The board of directors decided that if the conditions for lowering the conversion price are triggered again after March 24, 2026, a new meeting will be held to determine whether to exercise the right to lower the conversion price [2] Summary by Sections - Company Decision: The company held a board meeting on September 23, 2025, where it approved the proposal not to lower the conversion price of its convertible bonds [2] - Future Conditions: The company will not propose a downward adjustment of the conversion price until March 23, 2026, even if the conditions are met [2] - Post-2026 Review: After March 24, 2026, if the conditions for a downward adjustment are triggered again, the board will reconvene to decide on the matter [2]
共同药业：关于不向下修正共同转债转股价格的公告